CDKN1A and cancer: The tumour suppressor p53, which is deficient in 50% of all human cancers (Hussain and Harris, 2000), indirectly downregulates UHRF1 through the upregulation of p21/WAF1 and subsequent deactivation of E2F1 (Arima et al, 2004).